GemPharmatech Co., Ltd. (SHA:688046)
China
· Delayed Price · Currency is CNY 11.60
-0.13 (-1.11%)
At close: May 23, 2025, 2:57 PM CST
GemPharmatech Revenue
GemPharmatech had revenue of 170.86M CNY in the quarter ending March 31, 2025, with 8.76% growth. This brings the company's revenue in the last twelve months to 700.61M, up 9.65% year-over-year. In the year 2024, GemPharmatech had annual revenue of 686.84M with 10.39% growth.
Revenue (ttm)
700.61M
Revenue Growth
+9.65%
P/S Ratio
6.75
Revenue / Employee
443.98K
Employees
1,578
Market Cap
4.73B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |